The Flaws and Human Harms of Animal Experimentation

Cambridge Quarterly of Healthcare Ethics

Volumn 24, Issue 4, 2015, Pages 407-419

  Akhtar, Aysha ^a  

^a Oxford Centre for Animal Ethics   (United Kingdom)

Author keywords

animal ethics; Animal research; drug development; human ethics; human health; medical testing

Indexed keywords

ANIMAL; ANIMAL EXPERIMENT; ANIMAL RIGHTS; ANIMAL WELFARE; DISEASE MODEL; DRUG INDUSTRY; ETHICS; HUMAN; PROCEDURES; TOXICITY TESTING;

ANIMAL EXPERIMENTATION; ANIMAL RIGHTS; ANIMAL WELFARE; ANIMALS; DISEASE MODELS, ANIMAL; DRUG INDUSTRY; HUMANS; TOXICITY TESTS;

EID: 84941636370     PISSN: 09631801     EISSN: 14692147     Source Type: Journal    
DOI: 10.1017/S0963180115000079     Document Type: Article

References (89)

1. Taylor K, Gordon N, Langley G, Higgins W. Estimates for worldwide laboratory animal use in 2005. Alternatives to Laboratory Animals 2008 ; 36: 327-42.
2. Perel P, Roberts I, Sena E, Wheble P, Briscoe C, Sandercock P, et al. Comparison of treatment effects between animal experiments and clinical trials: Systematic review. BMJ 2007;334:197.
3. Pound P, Bracken MB. Is animal research suffi ciently evidence based to be a cornerstone of biomedical research? BMJ 2014;348:g3387.
4. Godlee F. How predictive and productive is animal research? BMJ 2014;348:g3719.
5. Benatar M. Lost in translation: Treatment trials in the SOD 1 mouse and in human ALS. Neurobiology Disease 2007; 26: 1-13.
6. Akhtar AZ, Pippin JJ, Sandusky CB. Animal studies in spinal cord injury: A systematic review of methylprednisolone . Alternatives to Laboratory Animals 2009 ; 37: 43-62.
7. Mathews RAJ. Medical progress depends on animal models-doesn't it? Journal of the Royal Society of Medicine 2008 ; 101: 95-8.
8. Shanks N, Greek R, Greek J. Are animal models predictive for humans? Philosophy, Ethics, and Humanities in Medicine 2009 ; 4: 2.
9. Wall RJ, Shani M. Are animal models as good as we think? Theriogenology 2008 ; 69: 2-9.
10. Hartung T, Zurlo J. Food for thought alternative approaches for medical countermeasures to biological and chemical terrorism and warfare. ALTEX 2012; 29: 251-60.
11. Leist M, Hartung T. Infl ammatory fi ndings on species extrapolations: Humans are defi nitely no 70-kg mice. Archives in Toxicology 2013 ; 87: 563-7.
12. Mak IWY, Evaniew N, Ghert M. Lost in translation: Animal models and clinical trials in cancer treatment. American Journal in Translational Research 2014 ; 6: 114-18.
13. Pippin J. Animal research in medical sciences: Seeking a convergence of science, medicine, and animal law. South Texas Law Review 2013 ; 54: 469-511.
14. For an overview of the harms-versus-benefi ts argument, LaFollette H. Animal experimentation in biomedical research. In: Beauchamp TL, Frey RG, eds. The Oxford Handbook of Animal Ethics. Oxford: Oxford University Press ; 2011: 812-18.
15. Jucker M. The benefi ts and limitations of animal models for translational research in neurodegenerative diseases. Nature Medicine 2010; 16: 1210-14.
16. Institute of Medicine. Improving the Utility and Translation of Animal Models for Nervous System Disorders: Workshop Summary. Washington, DC: The National Academies Press; 2013.
17. Degryse AL, Lawson WE. Progress towards improving animal models for IPF. American Journal of Medical Science 2011 ; 341: 444-9.
18. Morgan KN, Tromborg CT. Sources of stress in captivity. Applied Animal Behaviour Science 2007 ; 102: 262-302.
19. Hart PC, Bergner CL, Dufour BD, Smolinsky AN, Egan RJ, LaPorte L, et al. Analysis of abnormal repetitive behaviors in experimental animal models. In Warrick JE, Kauleff AV, eds. Translational Neuroscience and Its Advancement of Animal Research Ethics. New York: Nova Science ; 2009: 71-82.
20. Lutz C, Well A, Novak M. Stereotypic and self-injurious behavior in rhesus macaques: A survey and retrospective analysis of environment and early experience. American Journal of Primatology 2003 ; 60: 1-15.
21. Balcombe JP, Barnard ND, Sandusky C. Laboratory routines cause animal stress. Contemporary Topics in Laboratory Animal Science 2004 ; 43: 42-51.
22. Suckow MA, Weisbroth SH, Franklin CL. The Laboratory Rat. 2nd ed. Burlington, MA: Elsevier Academic Press; 2006, 323.
23. Flow BL, Jaques JT. Effect of room arrangement and blood sample collection sequence on serum thyroid hormone and cortisol concentrations in cynomolgus macaques (Macaca fascicularis). Contemporary Topics in Laboratory Animal Science 1997;36:65-8.
24. Baldwin A, Bekoff M. Too stressed to work. New Scientist 2007;194:24.
25. Akhtar A, Pippin JJ, Sandusky CB. Animal models in spinal cord injury: A review. Reviews in the Neurosciences 2008 ; 19: 47-60.
26. Macleod MR, O'Collins T, Howells DW, Donnan GA. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 2004 ; 35: 1203-8.
27. O' Neil BJ, Kline JA, Burkhart K, Younger J. Research fundamentals: V. The use of laboratory animal models in research. Academic Emergency Medicine 1999;6:75-82.
28. Crabbe JC, Wahlsten D, Dudek BC. Genetics of mouse behavior: Interactions with laboratory environment . Science 1999 ; 284: 1670-2, at 1670.
29. Curry SH. Why have so many drugs with stellar results in laboratory stroke models failed in clinical trials? A theory based on allometric relationships. Annals of the New York Academy of Sciences 2003;993:69-74.
30. Dirnagl U. Bench to bedside: The quest for quality in experimental stroke research. Journal of Cerebral Blood Flow & Metabolism 2006 ; 26: 1465-78.
31. van der Worp HB, Howells DW, Sena ES, Poritt MJ, Rewell S, O'Collins V, et al. Can animal models of disease reliably inform human studies? PLoS Medicine 2010 ; 7: e1000245.
32. Sena E, van der Worp B, Howells D, Macleod M. How can we improve the pre-clinical development of drugs for stroke? Trends in Neurosciences 2007 ; 30: 433-9.
33. Gawrylewski A. The trouble with animal models: Why did human trials fail? The Scientist 2007;21:44.
34. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009 ; 40: 2244-50.
35. Wang MM, Guohua X, Keep RF. Should the STAIR criteria be modifi ed for preconditioning studies? Translational Stroke Research 2013 ; 4: 3-14.
36. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1,026 experimental treatments in acute stroke. Annals of Neurology 2006 ; 59: 467-7.
37. Perrin S. Preclinical research: Make mouse studies work. Nature 2014 ; 507: 423-5.
38. Wilkins HM, Bouchard RJ, Lorenzon NM, Linseman DA. Poor correlation between drug effi cacies in the mutant SOD1 mouse mode versus clinical trials of ALS necessitates the development of novel animal models for sporadic motor neuron disease. In: Costa A, Villalba E, eds. Horizons in Neuroscience Research. Vol. 5. Hauppauge, NY: Nova Science; 2011:1-39.
39. Traynor BJ, Bruijn L, Conwit R, Beal F, O'Neill G, Fagan SC, et al. Neuroprotective agents for clinical trials in ALS: A systematic assessment. Neurology 2006 ; 67: 20-7.
40. Sinha G. Another blow for ALS. Nature Biotechnology 2013 ; 31: 185.
41. Morales DM, Marklund N, Lebold D, Thompson HJ, Pitkanen A, Maxwell WL, et al. Experimental models of traumatic brain injury: Do we really need a better mousetrap? Neuroscience 2005 ; 136: 971-89.
42. Xiong YE, Mahmood A, Chopp M. Animal models of traumatic brain injury. Nature Reviews Neuroscience 2013 ; 14: 128-42.
43. Farber N. Drug development in brain injury. International Brain Injury Association ; available at http://www.internationalbrain.org/articles/drug-development-in-traumatic-brain-injury/(last accessed 7 Dec 2014).
44. Maas AI, Roozenbeek B, Manley GT. Clinical trials in traumatic brain injury: Past experience and current developments. Neurotherapeutics 2010 ; 7: 115-26.
45. Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, et al. Clinical trials and late-stage drug development in Alzheimer's disease: An appraisal from 1984 to 2014. Journal of Internal Medicine 2014 ; 275: 251-83.
46. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, et al. Genomic responses in mouse models poorly mimic human infl ammatory diseases. Proceedings of the National Academy of Sciences USA 2013 ; 110: 3507-12.
47. Palfreyman MG, Charles V, Blander J. The importance of using human-based models in gene and drug discovery. Drug Discovery World 2002 Fall: 33-40.
48. Harding A. More compounds failing phase I. The Scientist 2004 Sept 13; available at http://www. the-scientist.com/?articles.view/articleNo/23003/title/More-compounds-failing-Phase-I/(last accessed 2 June 2014).
49. Wiebers DO, Adams HP, Whisnant JP. Animal models of stroke: Are they relevant to human disease? Stroke 1990 ; 21: 1-3.
50. Lonjon N, Prieto M, Haton H, Brøchner CB, Bauchet L, Costalat V, et al. Minimum information about animal experiments: Supplier is also important. Journal of Neuroscience Research 2009; 87: 403-7.
51. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, et al. Heritability of nociception I: Responses of 11 inbred mouse strains on 12 measures of nociception. Pain 1999 ; 80: 67-82.
52. Tator H, Hashimoto R, Raich A, Norvell D, Fehling MG, Harrop JS, et al. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury. Journal of Neurosurgery: Spine 2012 ; 17: 157-229.
53. Odom DT, Dowell RD, Jacobsen ES, Gordon W, Danford TW, MacIsaac KD, et al. Tissue-specifi c transcriptional regulation has diverged signifi cantly between human and mouse. Nature Genetics 2007 ; 39: 730-2.
54. Horrobin DF. Modern biomedical research: An internally self-consistent universe with little contact with medical reality? Nature Reviews Drug Discovery 2003 ; 2: 151-4.
55. Vassilopoulous S, Esk C, Hoshino S, Funke BH, Chen CY, Plocik AM, et al. A role for the CHC22 clathrin heavy-chain isoform in human glucose metabolism. Science 2009 ; 324: 1192-6.
56. Guttman-Yassky E, Krueger JG. Psoriasis: Evolution of pathogenic concepts and new therapies through phases of translational research. British Journal of Dermatology 2007 ; 157: 1103-15.
57. The mouse model: Less than perfect, still invaluable. Johns Hopkins Medicine ; available at http://www.hopkinsmedicine.org/institute-basic-biomedical-sciences/news-events/articles-and-stories/model-organisms/201010-mouse-model.html (last accessed 10 Dec 2014)
58. Cavanaugh S, Pippin J, Barnard N. Animal models of Alzheimer disease: Historical pitfalls and a path forward. ALTEX online fi rst; 2014 Apr 10.
59. Woodroofe A, Coleman RA. ServiceNote: Human tissue research for drug discovery. Genetic Engineering and Biotechnology News 2007 ; 27: 18.
60. Lane E, Dunnett S. Animal models of Parkinson's disease and L-dopa induced dyskinesia: How close are we to the clinic? Psychopharmacology 2008 ; 199: 303-12.
61. Bailey J. An assessment of the role of chimpanzees in AIDS vaccine research. Alternatives to Laboratory Animals 2008 ; 36: 381-428.
62. Tonks A. The quest for the AIDs vaccine. BMJ 2007 ; 334: 1346-8.
63. Johnston MI, Fauci AS. An HIV vaccine-evolving concepts. New England Journal of Medicine 2007 ; 356: 2073-81.
64. Rossouw JE, Andersen GL, Prentice RL, LaCroix AZ, Kooperberf C, Stefanick ML, et al. Risks and benefi ts of estrogen plus progestin in healthy menopausal women: Principle results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
65. Andersen GL, Limacher A, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 2004 ; 291: 1701-12.
66. Lemere CA. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine. Progress in Brain Research 2009 ; 175: 83.
67. Allen A. Of mice and men: The problems with animal testing. Slate 2006 June 1; available at http://www.slate.com/articles/health-and-science/medical-examiner/2006/06/of-mice-or-men.html (last accessed 10 Dec 2014).
68. Attarwala H. TGN1412: From discovery to disaster. Journal of Young Pharmacists 2010 ; 2: 332-6.
69. Hogan RJ. Are nonhuman primates good models for SARS? PLoS Medicine 2006 ; 3: 1656-7.
70. Bailey J. Non-human primates in medical research and drug development: A critical review. Biogenic Amines 2005 ; 19: 235-55.
71. Lemon R, Dunnett SB. Surveying the literature from animal experiments: Critical reviews may be helpful-not systematic ones. BMJ 2005 ; 330: 977-8.
72. Roberts I, Kwan I, Evans P, Haig S. Does animal experimentation inform human health care? Observations from a systematic review of international animal experiments on fl uid resuscitation. BMJ 2002 ; 324: 474-6.
73. Heywood R. Target organ toxicity. Toxicology Letters 1981 ; 8: 349-58.
74. Fletcher AP. Drug safety tests and subsequent clinical experience. Journal of the Royal Society of Medicine 1978 ; 71: 693-6.
75. Greek R, Greek J. Animal research and human disease. JAMA 2000 ; 283: 743-4.
76. Food and Drug Administration. Development & approval process (drugs); available at http://www.fda.gov/Drugs/DevelopmentApprovalProcess/(last accessed 7 Dec 2014).
77. Drug discovery pipeline. IRSF; available at http://www.rettsyndrome.org/research-programs/programmatic-overview/drug-discovery-pipeline (last accessed 24 Sept 2014).
78. Follow the yellow brick road. Nature Reviews Drug Discovery 2003;2:167, at 167.
79. Hartung T. Per aspirin as astra Alternatives to Laboratory Animals 2009; 37(Suppl 2): 45-7.
80. Koppanyi T, Avery MA. Species differences and the clinical trial of new drugs: A review. Clinical Pharmacology and Therapeutics 1966 ; 7: 250-70.
81. Schneierson SS, Perlman E. Toxicity of penicillin for the Syrian hamster. Proceedings of the Society for Experimental Biology and Medicine 1956 ; 91: 229-30.
82. Oral bioavailability of blockbuster drugs in humans and animals. PharmaInformatic. available at http://www.pharmainformatic.com/html/blockbuster-drugs.html (last accessed 19 Sept 2014).
83. Sams-Dodd F. Strategies to optimize the validity of disease models in the drug discovery process. Drug Discovery Today 2006 ; 11: 355-63.
84. Zurlo J. No animals harmed: Toward a paradigm shift in toxicity testing. Hastings Center Report 2012 ; 42 Suppl:s 23-6.
85. Monastersky R. Protesters fail to slow animal research. Chronicle of Higher Education 2008:54.
86. Wadman M. NIH director grilled over translational research centre. Nature News Blog 2012 Mar 20. Available at http://blogs. nature.com/news/2012/03/nih-director-grilled-over-translational-research-center.html (last accessed 5 Mar 2015).
87. Greek R, Greek J. Is the use of sentient animals in basic research justifi able? Philosophy, Ethics, and Humanities in Medicine 2010 ; 5: 14.
88. DeGrazia D. Taking Animals Seriously: Mental Lives and Moral Status. New York: Cambridge University Press ; 1996: 116-23.
89. Akhtar A. Animals and Public Health: Why Treating Animals Better Is Critical to Human Welfare.Hampshire, UK: Palgrave Macmillan; 2012:chap. 5.